Nurses and Nurse Navigators in mHSPC Patient Care

Nurses and Nurse Navigators in Metastatic Hormone-Sensitive Prostate Cancer Patient Care

Prostate Cancer
Video Library
Frank dela Rama, BS, RN, ONN-CG, OCN
Clinical Nurse Specialist
Palo Alto, CA
Kathryn Bowman, BS, RN, ONN-CG, OCN
GU/Neuro Navigator, Oncology
Winston-Salem, NC

Featuring:

We are pleased to share our recent webinar on Metastatic Hormone-Sensitive Prostate Cancer. The webinar features Frank Dela Rama, RN, MS, AOCNS, AGN-BC (Clinical Nurse Specialist, Palo Alto, CA) and Kathryn Bowman, BS, RN, ONN-CG, OCN (GU/Neuro Navigator, Oncology, Winston-Salem, NC) discussing the biomarker testing landscape in prostate cancer as well as sharing their experiences and best practices to ensure patients receive biomarker testing at key treatment milestones. In addition, Frank and Kathryn discuss their best practices for recognizing and managing adverse events associated with the treatment of metastatic hormone-sensitive prostate cancer (mHSPC).

Download Transcript

Related Items

Prostate Cancer in the Spotlight: A Teachable Moment to Increase Awareness
By Sharon S. Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN
Prostate Cancer, Web Exclusives
June 2025 Vol 16, No 6
With former President Joe Biden’s prostate cancer diagnosis being thrust onto the world’s stage, it is imperative that we use this as a teachable opportunity to educate people about the disease—and to highlight how oncology navigators make a difference in prostate cancer care.
Empowering the Patient Voice: Genomic Testing and Cancer Care Decisions
By Frank dela Rama, BS, RN, ONN-CG, OCN; Sara Campbell, BS, BSN, OCN; Jim G.
Genetics & Genomics
Video Library
In this roundtable discussion presented by AONN+ and supported by Exact Sciences, a panel of experts discuss the critical role of nurse navigators in educating cancer patients about genomic testing and how to interpret the results.
Practical Applications and Clinical Utility of PYLARIFY® (piflufolastat F 18) Injection: An ¹⁸F-PSMA PET/CT Imaging Agent for Prostate Cancer
Interview with the Innovators, Prostate Cancer
Interview with the Innovators – December 2021
A series of interviews was recently conducted with a panel of experts on prostate cancer imaging modalities that included Steven Rowe, MD, PhD, Associate Professor of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, and Neal D. Shore, MD, FACS, CMO, Surgical Oncology/Urology Genesis Care, US; Director, CPI, Carolina Urologic Research Center, Myrtle Beach, SC.
Journal of Oncology Navigation & Survivorship

Contact Us | Editorial Board

Amplity

© Amplity, Inc. All rights reserved.

Connect with Us

 
 
JONS

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
    Profession or Role
    Primary Specialty or Disease State
    Country

Back to Top

Amplity © Amplity, Inc. All rights reserved.